← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
CGTBiologicstaleChongqing Precision Biotech Co.…Phase 1

CD70 CAR T-cells (CD70 CAR T-cells)

Metastatic Tumor; Advanced Solid Tumor · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 3상태 ACTIVE
ADCBiologicstaleConvalife (Shanghai) Co., Ltd.Phase 2

CVL006 (CVL006)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
ADCBiologicstaleGSKPhase 2

belantamab mafodotin (Blenrep, GSK2857916, Carfilzomib, Lenalidomide, Dexamethasone, Belantamab Mafodotin)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 3상태 RECRUITING
AntibodystaleUCB PharmaApproved

CZP (Certolizumab Pegol, Certolizumab Pegol (CZP))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+2
임상시험 3상태 ACTIVE
ADCBiologicstaleSeagenPreclinical

Brentuximab vedotin plus chidamide (Consolidation therapy- 3 or 6 cycles of BvC, Consolidation therapy- 3 or 6 cycles of BvC(Brentuximab vedotin plus chidamide))

CD30+ Peripheral T-cell Lymphoma · CD30

#CD30#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
ADCBiologicstaleGenentech, Inc.Phase 2

DNIB0600A (DNIB0600A)

Non-Squamous Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer, Ovarian Canc

#Non-SmallCellLungCancerOvarianCa#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 ACTIVE
ADCBiologicstaleVerastem, Inc.Phase 2

Defactinib Hydrochloride (Defactinib Hydrochloride)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 3.2%임상시험 3상태 RECRUITING
ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin+Anlotinib)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 3상태 ACTIVE
CGTBiologicstaleBeijing BiotechPhase 2

EB-DT-CAR-NK (EB-DT-CAR-NK)

Advanced Gastric Adenocarcinoma; Advanced Gastroesophageal Junction Adenocarcinoma · Advanced Gastric Adenocarcinoma

#AdvancedGastricAdenocarcinoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 RECRUITING
CGTBiologicstaleImmunityBio, Inc.Phase 2

PSA-based Oncolytic Virus (ETBX-071, ETBX-071 (PSA-based Oncolytic Virus))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#세포유전치료#CAR-T+2
효능 ORR 0%임상시험 3상태 DISCONTINUED
CGTBiologicstaleNanjing IASO Biotechnology Co.,…Phase 2

Eque-cel CAR-T Therapy (Eque-cel CAR-T Therapy)

AL Amyloidosis · AL Amyloidosis

#ALAmyloidosis#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 3상태 RECRUITING
AntibodystaleEli LillyPreclinical

Cetuximab (Erbitux, Erbitux (Cetuximab))

Colorectal Neoplasms · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Preclinical#항체#면역항체+2
임상시험 3상태 ACTIVE
AntibodystaleHoffmann-La RochePhase 3

Etrolizumab (Etrolizumab)

Ulcerative Colitis · Ulcerative Colitis

#UlcerativeColitis#Antibody#Phase3#항체#면역항체+2
임상시험 3상태 ACTIVE
AntibodystaleAVEO Pharmaceuticals, Inc.Phase 2

Ficlatuzumab (Ficlatuzumab)

Head and Neck Basaloid Carcinoma; Recurrent Head and Neck Squamous Cell Carcinoma · Carcinoma, Squamous Cell of Head and Nec

#CarcinomaSquamousCellofHeadandNe#Antibody#Phase2#항체#면역항체+4
효능 ORR 1%임상시험 3상태 ACTIVE
ADCBiologicstaleGI Innovation, Inc.Phase 2

GI-102 (GI-102)

Advanced Solid Tumor; Metastatic Solid Tumor · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 3상태 RECRUITING
CGTBiologicstaleNanoscope Therapeutics Inc.Phase 2

Gene Therapy product-MCO-010 (Gene Therapy product-MCO-010)

Retinitis Pigmentosa; Retinitis · Retinitis Pigmentosa

#RetinitisPigmentosa#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 3상태 ACTIVE
ADCBiologicstaleGruppo Italiano Malattie EMatol…Phase 3

Gilteritinib Fumarate (Gilteritinib Fumarate)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 3상태 RECRUITING
ADCBiologicstaleHarpoon Therapeutics, Inc., a s…Phase 2

Gocatamig (Gocatamig)

Small-Cell Lung Cancer; Neuroendocrine Carcinoma · Small-Cell Lung Cancer

#Small-CellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

H1: TROP2 ADC (H1: TROP2 ADC)

Triple-negative Breast Cancer · TROP2

#TROP2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
ADCBiologicstaleShanghai JMT-Bio Inc.Phase 3

HB1801 (HB1801)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 3상태 RECRUITING

60 / 209 페이지

← 이전다음 →